Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease

Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease

US Patent 12421229 · Granted Sep 23, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Triazatricycle compounds for the treatment of autoimmune disease2025
Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune diseas2025
Method for extraction and purification of hirudin mutant and use thereof2025
Bacillus subtilis natto and method for producing MK-72025
Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune dis2025
Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune dis2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
Dihydrobenzimidazolones for medical treatment2025
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepati2025
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepati2025